Summary
Cultured skin fibroblasts from a 2-year-old boy with an atypical form of β-galactosidase deficiency have been studied. With the artificial substrate 4-methylumbelliferyl-β-D-galactopyranoside, 5–15% residual activity was found in fibroblasts from this patient. Most of this activity was in the monomeric A form of the enzyme, very little in the multimeric B form. Km value, pH profile, and heat lability of the mutant enzyme were similar to those of β-galactosidase from control fibroblasts. Immunological studies showed that the mutant enzyme cross-reacted with an antiserum raised against human liver β-galactosidase, but the catalytic activity per unit antigenic activity was lower than normal. It was demonstrated by somatic cell hybridization that the gene mutation in this patient is different from that in patients with type 1 or type 2 GM1-gangliosidosis. No genetic complementation was found after fusion of fibroblasts from this patient with those from two other clinical variants of GM1-gangliosidosis formerly designated type 3 and adult type 4.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andria, G., Del Giudice, E., Reuser, A. J. J.: Atypical expression of β-galactosidase deficiency in a child with Hurler-like features but without neurological abnormalities. Clin. Genet. 14, 16–23 (1978)
Galjaard, H., Hoogeveen, A., Keijzer, W., De Wit-Verbeek, H. A., Reuser, A. J. J., Ho, M. W., Robinson, D.: Genetic heterogeneity in GM1-gangliosidosis. Nature 257, 60–62 (1975)
Galjaard, H., Hoogeveen, A., De Wit-Verbeek, H. A., Reuser, A. J. J., Keijzer, W., Westerveld, A., Bootsma, D.: Tay-Sachs and Sandhoff's disease: Intergenic complementation after somatic cell hybridization. Exp. Cell Res. 87, 444–448 (1974)
Galjaard, H., Reuser, A. J. J.: Clinical, biochemical and genetic heterogeneity in gangliosidoses. In: Inborn errors of metabolis: ‘The cultured cell’ R. A. Harkness, F. Cockburn, eds., pp. 139–160. Lancaster: MTP Press 1977
Ho, M. W., O'Brien, J. S.: Hurler's syndrome: Deficiency of a specific beta galactosidase isoenzyme. Science 165, 611–613 (1969)
Ho, M. W., O'Brien, J. S.: Differential effect of chloride ions on β-galactosidase isoenzymes: A method for separate assay. Clin. Chim. Acta 32, 443–450 (1971)
Loonen, M. C. B., Van der Lugt, L., Franke, C. L.: Angiokeratoma corporis diffusum and lysosomal enzyme deficiency. Lancet 1974 II, 785
Norden, A. G. W., O'Brien, J. S.: An electroforetic variant of β-galactosidase with altered properties in a patient with GM1-gangliosidosis. Proc. Natl. Acad. Sci. USA 72, 240–244 (1975)
O'Brien, J. S.: Ganglioside storage diseases. In: Advances in human genetics, H. Harris, K. Hirschhorn, eds., Vol. 3, pp. 39–98. New York: Plenum 1972
O'Brien, J. S.: Molecular genetics of GM1-β-galactosidase. Clin. Genet. 8, 303–313 (1975)
O'Brien, J. S., Gugler, E., Giedion, A., Wiessmann, U., Herschkowitz, N., Meier, C., Leroy, J.: Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid β-galactosidase deficiency. Clin. Genet. 9, 495–504 (1976)
O'Brien, J. S., Ho, M. W., Veath, M. L.: Juvenile GM1-gangliosidosis; clinical, pathological, chemical and enzymatic studies. Clin. Genet. 3, 411–434 (1972)
O'Brien, J. S., Norden, A. G. W.: Nature of the mutation in adult β-galactosidase deficient patients. Am. J. Hum. Genet. 29, 184–190 (1977)
Okada, S., O'Brien, J. S.: Generalized gangliosidosis; β-galactosidase deficiency. Science 160, 1002–1004 (1968)
Orii, T., Sukegawa, K., Kudoh, T., Horino, K., Nakao, T.: Three GM1-gangliosidoses and a variant of β-galactosidase deficiency. J. Exp. Med. 117, 197–198 (1975)
Pinsky, L., Miller, J., Stanfield, B., Watters, G., Wolfe, L. S.: GM1-gangliosidosis in skin fibroblast culture: Enzymatic differences between types 1 and 2 and observations on a third variant. Am. J. Hum. Genet. 26, 563–577 (1974)
Suzuki, Y., Nakamura, N., Shimada, Y., Yotsumeto, H., Endo, H., Nagashima, K.: Macular cherry-red spots and β-galactosidase deficiency in an adult. Arch. Neurol. 34, 157–161 (1977)
Wenger, D. A., Goodman, S. I., Meyers, G. M.: β-galactosidase deficiency in young adults. Lancet 1974 II, 1319–1320
Wit, J. de, Hoeksema, H. L., Halley, D., Hagemeijer, A., Bootsma, D., Westerveld, A.: Regional localization of a β-galactosidase locus on human chromosome 22. Somat. Cell Genet. 3, 351–363 (1977)
Wolfe, L. S., Callahan, J., Fawcett, J. S., Andermann, F., Scriver, C. R.: GM1-gangliosidosis without chondrodystrophy or visceromegaly. Neurology (Minneap.) 20, 23–44 (1970)
Yamamoto, A., Adachi, S., Kawamura, S., Takahashi M., Ohtori, T., Shinji, Y., Nishikawa, M.: Localized β-galactosidase deficiency. Occurrence in cerebellar ataxia with myoclonus, epilepsy and macular cherry red spot. A new variant of GM1-gangliosidosis? Arch. Intern. Med. 134, 627–634 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reuser, A.J.J., Andria, G., de Wit-Verbeek, E. et al. A two-year-old patient with an atypical expression of GM1-β-galactosidase deficiency: Biochemical, immunological, and cell genetic studies. Hum Genet 46, 11–19 (1979). https://doi.org/10.1007/BF00278897
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00278897